Testosterone Drug Approved

Acrux Limited (ASX:ACR) and Eli Lilly Company (LLY) announced that the FDA has approved the Axiron® topical solution CIII for testosterone replacement therapy in men. Axiron is the first testosterone topical solution approved for application via an underarm applicator.

Be the first to comment

Leave a Reply

Your email address will not be published.